Pallas Capital Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$838K	Sell	2,570 -4,065	-61%	-$1.33M	0.03%	368
2025 Q1	$1.79M	Buy	6,635 +3,227	+95%	+$871K	0.07%	198
2024 Q4	$802K	Buy	3,408 +87	+3%	+$20.5K	0.03%	280
2024 Q3	$975K	Buy	3,321 +1,269	+62%	+$373K	0.04%	228
2024 Q2	$486K	Buy	+2,052	New	+$486K	0.02%	312